|
|
|
|
Inflammation Fuels Colicin Ib-Dependent Competition of Salmonella Serovar Typhimurium and E. coli in Enterobacterial Blooms
|
|
|
|
|
|
|
|
نویسنده
|
nedialkova l.p. ,denzler r. ,koeppel m.b. ,diehl m. ,ring d. ,wille t. ,gerlach r.g. ,stecher b.
|
|
منبع
|
plos pathogens - 2014 - دوره : 10 - شماره : 1
|
|
چکیده
|
The host's immune system plays a key role in modulating growth of pathogens and the intestinal microbiota in the gut. in particular,inflammatory bowel disorders and pathogen infections induce shifts of the resident commensal microbiota which can result in overgrowth of enterobacteriaceae (inflammation-inflicted blooms). here,we investigated competition of the human pathogenic salmonella enterica serovar typhimurium strain sl1344 (s. tm) and commensal e. coli in inflammation-inflicted blooms. s. tm produces colicin ib (colib),which is a narrow-spectrum protein toxin active against related enterobacteriaceae. production of colib conferred a competitive advantage to s. tm over sensitive e. coli strains in the inflamed gut. in contrast,an avirulent s. tm mutant strain defective in triggering gut inflammation did not benefit from colib. expression of colib (cib) is regulated by iron limitation and the sos response. cira,the cognate outer membrane receptor of colib on colicin-sensitive e. coli,is induced upon iron limitation. we demonstrate that growth in inflammation-induced blooms favours expression of both s. tm colib and the receptor cira,thereby fuelling colib dependent competition of s. tm and commensal e. coli in the gut. in conclusion,this study uncovers a so-far unappreciated role of inflammation-inflicted blooms as an environment favouring colib-dependent competition of pathogenic and commensal representatives of the enterobacteriaceae family. © 2014 nedialkova et al.
|
|
|
|
|
آدرس
|
max-von-pettenkofer institute,lmu munich,munich,germany,german center for infection research (dzif),partner site lmu munich,munich, Germany, institute of microbiology,eth zürich,zürich,switzerland,institute of molecular health sciences,zürich, Switzerland, max-von-pettenkofer institute,lmu munich,munich,germany,german center for infection research (dzif),partner site lmu munich,munich, Germany, max-von-pettenkofer institute,lmu munich,munich,germany,german center for infection research (dzif),partner site lmu munich,munich, Germany, max-von-pettenkofer institute,lmu munich,munich,germany,german center for infection research (dzif),partner site lmu munich,munich, Germany, robert koch-institut,wernigerode branch,junior research group 3,wernigerode, Germany, robert koch-institut,wernigerode branch,junior research group 3,wernigerode, Germany, max-von-pettenkofer institute,lmu munich,munich,germany,german center for infection research (dzif),partner site lmu munich,munich, Germany
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Authors
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|